Lever Bio

📍 Turin, Italy🗓 Founded 2024👥 7 employees💰 Last funded Dec 2025
Biotechnology Research
LinkedIn
Lever Bios goal is to develop novel immunomodulatory antibody-based therapeutics to overcome resistance to current immunotherapies, paving the way for next-generation immunotherapies and innovative combination treatments. Lever Bios compounds target components of the solid tumor microenvironment to foster anti-cancer immune response enhancing recruitment, activation and sustained function of cytotoxic T lymphocytes against solid tumors.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2024
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Italy
1
Frequently asked questions
Who invested in Lever Bio?
Lever Bio has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Lever Bio last raise funding?
The most recent investment in Lever Bio recorded on gritt.io was in December 2025.
When was Lever Bio founded?
Lever Bio was founded in 2024.
What industry is Lever Bio in?
Lever Bio operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Lever Bio based?
Lever Bio is headquartered in Turin, Italy.